TRVI
NASDAQ · Pharmaceuticals
Trevi Therapeutics Inc
$17.21
+0.84 (+5.13%)
Open$16.90
Previous Close$16.37
Day High$17.61
Day Low$16.48
52W High$17.61
52W Low$5.41
Volume—
Avg Volume1.62M
Market Cap2.44B
P/E Ratio—
EPS$-0.32
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+27.4% upside
Current
$17.21
$17.21
Target
$21.93
$21.93
$18.04
$21.93 avg
$33.12
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 772.80M | 683.27M | 746.33M |
| Net Income | 98.54M | 104.02M | 99.75M |
| Profit Margin | 12.8% | 15.2% | 13.4% |
| EBITDA | 196.14M | 177.32M | 185.79M |
| Free Cash Flow | 50.24M | 55.58M | 60.41M |
| Rev Growth | +0.7% | +7.7% | +15.7% |
| Debt/Equity | 0.64 | 0.66 | 0.70 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |